company background image
VAPO logo

Vapotherm OTCPK:VAPO Stock Report

Last Price

US$1.33

Market Cap

US$8.2m

7D

-4.3%

1Y

-71.8%

Updated

27 Mar, 2024

Data

Company Financials

VAPO Stock Overview

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally.

VAPO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Vapotherm, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vapotherm
Historical stock prices
Current Share PriceUS$1.33
52 Week HighUS$7.44
52 Week LowUS$0.75
Beta-1.15
1 Month Change40.74%
3 Month Change18.75%
1 Year Change-71.83%
3 Year Change-99.31%
5 Year Change-99.17%
Change since IPO-98.96%

Recent News & Updates

Recent updates

Vapotherm announces $23M private placement

Feb 08

Vapotherm GAAP EPS of -$0.98 misses by $0.20, revenue of $13.5M misses by $3.02M

Nov 02

Vapotherm draws downgrade at William Blair after 2Q results

Aug 04

Vapotherm: Out Of Air

May 11

Is Vapotherm (NYSE:VAPO) Using Too Much Debt?

Jan 24
Is Vapotherm (NYSE:VAPO) Using Too Much Debt?

Vapotherm: Hardly Breathing Room

Jul 11

Health Check: How Prudently Does Vapotherm (NYSE:VAPO) Use Debt?

May 10
Health Check: How Prudently Does Vapotherm (NYSE:VAPO) Use Debt?

Vapotherm reports Q1 results

May 05

The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares

Mar 12
The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares

Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year

Mar 11
Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year

Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?

Jan 19
Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?

Vapotherm guides Q4 revenue above consensus, ~212% Y/Y growth

Jan 13

Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares

Dec 14
Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares

Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%

Dec 11
Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%

Vapotherm shares +9% on higher Q4 guidance

Dec 01

Vapotherm: The Game Has Completely Changed

Nov 13

Shareholder Returns

VAPOUS Medical EquipmentUS Market
7D-4.3%2.2%0.4%
1Y-71.8%13.3%28.8%

Return vs Industry: VAPO underperformed the US Medical Equipment industry which returned 12% over the past year.

Return vs Market: VAPO underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is VAPO's price volatile compared to industry and market?
VAPO volatility
VAPO Average Weekly Movement13.8%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: VAPO's share price has been volatile over the past 3 months.

Volatility Over Time: VAPO's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1993182Joe Armyhttps://www.vapotherm.com

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation.

Vapotherm, Inc. Fundamentals Summary

How do Vapotherm's earnings and revenue compare to its market cap?
VAPO fundamental statistics
Market capUS$8.25m
Earnings (TTM)-US$58.19m
Revenue (TTM)US$68.67m

0.1x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VAPO income statement (TTM)
RevenueUS$68.67m
Cost of RevenueUS$40.33m
Gross ProfitUS$28.34m
Other ExpensesUS$86.53m
Earnings-US$58.19m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-9.38
Gross Margin41.27%
Net Profit Margin-84.74%
Debt/Equity Ratio-193.5%

How did VAPO perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.